Complegen Partners, Inc.

Complegen, Inc.

John Swindle

Rich B Meyer

Janet Ajioka

Heidi S Hummel

Dean Dawson

The present invention provides a method of selectively inhibiting PKC&#x3b8; in the presence of PKC&#x3b4;, by administering to a subject in need thereof, a therapeutically effective amount of a compound of Formula I. The present invention also provides a method of inhibiting cytokine synthesis in a T cell, a method of inhibiting T cell proliferation, and a method of inhibiting the replication of and cytokine production by T lymphocytes, while not stimulating or inhibiting the replication of B lymphocytes.

Compounds and methods for PKC&#x3b8; inhibition

Compounds and methods for PKC theta inhibition

This invention relates to functional gene arrays of yeast. Novel aspects include the individual yeast cells, methods for making the yeast and the arrays, the arrays and uses for the arrays. A diploid bearing special genetic properties has been constructed to facilitate cloning of heterologous genes capable of providing essential functions. A selection method, using this strain allows the identification haploid yeast strains dependent for life on heterologous essential genes. The arrays of these strains comprise a library of unique members where each member is dependent for survival on the function of a heterologous gene complementing a different essential host gene which has been inactivated by the insertion of a dominant selectable marker. These arrays provide screening platforms for agents that specifically target the activity of these heterologous genes.

Functional gene array in yeast

Growing community of inventors

Seattle, WA, United States of America

John Swindle